4 withdrawn. 4 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Withdrawn 4 |
| Phase 1 | 1 | Withdrawn 1 |
| Phase 3 | 1 | Withdrawn 1 |
Follow Acid-Base Imbalance: new trials by email Literature Review of Acid-Base Imbalance trials Research Report on Acid-Base Imbalance
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Impact of Exogenous Ketones on Sleep Apnea Ketone-IQ, Placebo - Obstructive Sleep Apnea, Sleep | Phase 1 / Phase 2 | Withdrawn | Johns Hopkins University | 2025-01-29 | 2026-09-21 | |
| Metformin in Moderate and Severe Renal Failure (CKD 3-4): A Follow-up Study Metformin - Renal Insufficiency, Chronic | Phase 2 | Withdrawn | Centre Hospitalier Universitaire, Amiens | 2016-03-16 | 2020-07-15 | |
| Phase 2c Dose Comparison Study of MP4OX in Trauma MP4OX, Control - Trauma, Hemorrhagic Shock | Phase 2 | Withdrawn | Sangart | 2013-12-01 | 2013-10-31 | |
| AC-1204 Long-term Efficacy Response Trial (ALERT Protocol) caprylic triglyceride, long-chain triglyceride - Alzheimer's Disease | Phase 2 / Phase 3 | Withdrawn | Cerecin | 2012-12-04 |
Acidosis, Lactic (2) · Ketosis (2) · Alzheimer Disease (1) · Hemorrhage (1) · Hyperlactatemia (1) · Renal Insufficiency (1) · Renal Insufficiency, Chronic (1) · Shock, Hemorrhagic (1) · Sleep Apnea Syndromes (1) · Sleep Apnea, Obstructive (1) · Wounds and Injuries (1)
Acidosis (4) · Metabolic Diseases (4) · Nutritional and Metabolic Diseases (4) · Nervous System Diseases (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Apnea (1) · Brain Diseases (1) · Central Nervous System Diseases (1) · Chronic Disease (1) · Dementia (1) · Disease Attributes (1) · Dyssomnias (1) · Female Urogenital Diseases (1)
Metformin (1) · PEG-hemoglobin (1) · Sunflower Oil (1) · maleimide-polyethylene glycol-modified hemoglobin, MP4 (1) · maltodextrin (1) · polynitroxylated pegylated hemoglobin (1) · tricaprylin (1)
Centre Hospitalier Universitaire, Amiens (1) · Cerecin (1) · Johns Hopkins University (1) · Sangart (1)
France (2) · United States (2) · Australia (1) · Belgium (1) · Brazil (1) · Germany (1) · Israel (1) · New Zealand (1) · Norway (1) · South Africa (1) · Switzerland (1) · United Kingdom (1)
Frank V. Booth, BCh, FACS (1) · Jonathan Jun, MD (1) · Karim Brohi, MD (1) · Mildred Farmer, MD (1)